ORAMED PHARMACEUTICALS INC. (ORMP)

Pharmaceutical Preparations · Healthcare · $1.2B

overvalued
Intrinsic Value (Consensus)
$19.13
Current Price
$30.00
Margin of Safety
-36.2%
36.2% Above Intrinsic Value
Value: $19
Price: $30

Valuation Model Estimates

Current Price: $30.00
DCF (Discounted Cash Flow)
Not applicable
Graham Number
$12.83
Earnings Power Value
$14.56
Relative Value (P/E)
$30.00
Dividend Discount Model
Not applicable
Consensus Value
$19.13

Model Assumptions

Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%

Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.

Key Financials

EPS (TTM)
$1.50
EPS (Forward)
$1.58
Book Value
$4.88
P/E Ratio
20.0
Forward P/E
19.0
PEG Ratio
ROE
32.1%
Debt/Equity
0%
Revenue Growth
49.3%
Earnings Growth
5.0%
Dividend Yield
N/A
Beta
1.00

Data last updated: 2026-06-12

Source: Yahoo Finance